158 related articles for article (PubMed ID: 6145570)
1. The neuroleptic malignant syndrome: presentation and treatment.
Birkhimer LJ; DeVane CL
Drug Intell Clin Pharm; 1984 Jun; 18(6):462-5. PubMed ID: 6145570
[TBL] [Abstract][Full Text] [Related]
2. The neuroleptic malignant syndrome. A priority system.
Neppe VM
S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic malignant syndrome.
Keltner NL; McIntyre CW
J Neurosurg Nurs; 1985 Dec; 17(6):362-6. PubMed ID: 2868079
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic catatonia and its relationship to psychogenic catatonia.
Fricchione GL
Biol Psychiatry; 1985 Mar; 20(3):304-13. PubMed ID: 2858225
[TBL] [Abstract][Full Text] [Related]
5. Therapy of syndrome malin.
Conner CS
Drug Intell Clin Pharm; 1983 Sep; 17(9):639-40. PubMed ID: 6137352
[TBL] [Abstract][Full Text] [Related]
6. [Neuroleptic malignant syndrome and related conditions].
Amore M; Montanari M
Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Stoudemire A; Luther JS
Int J Psychiatry Med; 1984; 14(1):57-63. PubMed ID: 6145675
[TBL] [Abstract][Full Text] [Related]
8. General anesthesia after neuroleptic malignant syndrome.
Lotstra F; Linkowski P; Mendlewicz J
Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
[TBL] [Abstract][Full Text] [Related]
9. Detection and management of the neuroleptic malignant syndrome.
Bond WS
Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
[TBL] [Abstract][Full Text] [Related]
10. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
Schröder J; Linge C; Wähner A
Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome.
Rampertaap MP
South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330
[TBL] [Abstract][Full Text] [Related]
12. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome.
Scarlett JD; Zimmerman R; Berkovic SF
Aust N Z J Med; 1983 Feb; 13(1):70-3. PubMed ID: 6136267
[No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome.
Cope RV
Br J Psychiatry; 1983 Aug; 143():202-3. PubMed ID: 6137256
[No Abstract] [Full Text] [Related]
15. Pathogenesis and treatment of neuroleptic malignant syndrome.
Ebadi M; Pfeiffer RF; Murrin LC
Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
[TBL] [Abstract][Full Text] [Related]
16. Current concepts. Neuroleptic malignant syndrome.
Guzé BH; Baxter LR
N Engl J Med; 1985 Jul; 313(3):163-6. PubMed ID: 3892294
[No Abstract] [Full Text] [Related]
17. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome. Reappraisal apropos of 2 cases].
Bourgeois M; Tignol J; Villeger M; Henry P; Daubech JF; Laforge E; Durand J
Ann Med Psychol (Paris); 1981 May; 139(5):547-56. PubMed ID: 6118087
[No Abstract] [Full Text] [Related]
19. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
Weinberger DR; Kelly MJ
J Nerv Ment Dis; 1977 Oct; 165(4):263-8. PubMed ID: 908924
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome.
Knezevic W; Mastaglia FL; Lefroy RB; Fisher A
Med J Aust; 1984 Jan; 140(1):28-30. PubMed ID: 6146918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
